查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612890

細胞培養市場：按產品、應用和最終用途 - 2025-2030 年全球預測

Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年細胞培養市場價值為262.9億美元，預計到2024年將達到301.2億美元，複合年成長率為14.58%，到2030年將達到682億美元。

細胞培養市場涉及在受控條件下在自然環境之外培養細胞，在生物研究、生物製藥生產以及疫苗和治療性蛋白質的製造中發揮至關重要的作用。由於生物技術的擴展、再生醫學需求的快速增加以及對個人化醫療的日益關注，對此的需求正在增加。主要應用包括生物生產、藥物發現、組織工程和臨床應用，最終用戶範圍從製藥公司和生物技術公司到研究機構和醫院。該市場的成長受到自動化細胞培養系統技術進步、細胞研究資金增加以及需要創新治療方法的慢性疾病盛行率上升的影響。 3D細胞培養系統的開發存在重大機遇，可提供更好的生物模擬和基於細胞的產品製造的進步。公司可以透過與學術機構合作促進創新和建立生物庫來支持個人化醫療而受益。然而，培養基和設備的高成本、有關動物性培養成分的倫理問題以及嚴格的法律規範等挑戰可能會抑制生長。創新應著重於開發具有成本效益的介質和設備，整合人工智慧以提高實驗室自動化，並增強大批量生產的製程可擴展性。鑑於市場的動態性質，以快速的技術發展和廣泛的跨部門合作為特徵，業務成長的最佳路徑是在政府政策支持和醫療保健投資不斷增加的新興市場。透過建立強大的供應鏈並融入永續實踐，您可以變得更具競爭力。對於希望增加市場佔有率的公司來說，研發方面的策略性投資以及專注於為不同行業量身定做的解決方案代表著巨大的成長和成功潛力。

主要市場統計
基準年[2023] 262.9億美元
預計年份 [2024] 301.2億美元
預測年份 [2030] 682億美元
複合年成長率（%） 14.58%

市場動態：揭示快速發展的細胞培養市場的關鍵市場洞察

供需的動態交互作用正在改變細胞培養市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對治療用途單株抗體的需求不斷成長
    • 增加對生物技術和藥物研究活動的投資
    • 全球慢性病盛行率上升
  • 市場限制因素
    • 與先進細胞培養技術和維持無菌條件相關的高成本
  • 市場機會
    • 擴大細胞培養在個人化醫療中的使用，提供個人遺傳特徵的治療
    • 利用細胞培養進行永續食品生產的培養肉需求迅速成長
  • 市場問題
    • 培養物維護的複雜性與污染風險

波特的五力：駕馭細胞培養市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞培養市場的外部影響

外部宏觀環境因素在塑造細胞培養市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解細胞培養市場的競爭格局

對細胞培養市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：細胞培養市場供應商的績效評估

FPNV定位矩陣是評估細胞培養市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製細胞培養市場的成功之路

細胞培養市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對治療用途單株抗體的需求增加
      • 增加對生物技術和藥物研究活動的投資
      • 世界各地慢性病的發生率正在上升
    • 抑制因素
      • 先進的細胞培養技術和維持無菌條件相關的高成本
    • 機會
      • 擴大細胞培養在個人化醫療的應用，根據個體的遺傳特徵客製化治療方案
      • 利用細胞培養實現永續食品生產的培養肉需求不斷成長
    • 任務
      • 培養物維護的複雜性與污染風險
  • 市場區隔分析
    • 產品：可靠、可擴展且先進的細胞培養設備正在成為優先考慮的因素
    • 最終用途：擴大細胞培養在醫院和診斷實驗室的使用，以提高效率和診斷準確性
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章細胞培養市場：依產品

  • 介紹
  • 消耗品
    • 反應器配件
    • 血清、培養基、試劑
      • 中等的
      • 經典介質和鹽
      • 無血清培養基
      • 特殊介質
      • 幹細胞培養基
      • 試劑
      • 抗生素/抗真菌藥
      • 附件和矩陣因子
      • 平衡鹽溶液
      • 緩衝液和化學品
      • 細胞分離試劑
      • 污染檢測套件
      • 防凍試劑
      • 血清
      • 牛血清
      • 牛
    • 容器
      • 電池工廠系統/電池堆
      • 燒瓶
      • 多孔孔盤
      • 培養皿
      • 滾筒/婁瓶
  • 裝置
    • 反應器
      • 常規反應器
      • 反應器
    • 倉儲設備
      • 冷凍系統
      • 冰箱/冷凍庫
    • 支援設備
      • 高壓釜
      • 生物安全櫃
      • 二氧化碳培養箱
      • 細胞計數器
      • 離心機
      • 過濾系統
      • 顯微鏡

第7章細胞培養市場：依應用分類

  • 介紹
  • 生物製藥製造
    • 單株抗體的生產
    • 疫苗生產
  • 診斷
  • 藥物篩檢與開發
  • 幹細胞研究
  • 組織工程與再生醫學

第8章細胞培養市場：依最終用途

  • 介紹
  • 醫院和診斷實驗室
  • 製藥和生物技術公司
  • 研究/學術機構

第9章美洲細胞培養市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太細胞培養市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲細胞培養市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 諾華在奧地利生物製藥製造領域啟動 5 億美元擴建計劃
    • Molecular Devices 宣布推出 CellXpress AI 自動化系統
    • 策略夥伴關係提高幹細胞研究的可及性和效率
  • 戰略分析和建議

公司名單

  • Adolf Kuhner AG
  • Advancion Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson, and Company
  • Bio-Techne Corporation
  • BioSpherix Ltd.
  • Caisson Labs Inc.
  • CellGenix GmbH
  • Corning Incorporated
  • Danaher Corporation
  • Emulate, Inc.
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Hi-Media Laboratories
  • InSphero AG
  • Invivogen
  • Lonza Group
  • Merck & Co., Inc.
  • Miltenyi BIoTec
  • PAN-BIoTech GmbH
  • PromoCell GmbH
  • Sartorius AG
  • Solida BIoTech GmBH
  • STEMCELL Technologies Canada Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC by Avantor, Inc.
Product Code: MRR-034230D3E63B

The Cell Culture Market was valued at USD 26.29 billion in 2023, expected to reach USD 30.12 billion in 2024, and is projected to grow at a CAGR of 14.58%, to USD 68.20 billion by 2030.

The cell culture market involves the cultivation of cells outside their natural environment under controlled conditions and plays a pivotal role in biological research, biopharmaceutical production, and manufacturing of vaccines and therapeutic proteins. It is increasingly necessary due to the expansion of biotechnology, the surge in demand for regenerative medicine, and the increasing focus on personalized medicine. Key applications include bioproduction, drug discovery, tissue engineering, and clinical applications with end users spanning pharmaceutical and biotechnology companies, research institutes, and hospitals. Growth in this market is influenced by technological advancements in automated cell culture systems, increased funding for cell-based research, and the rising prevalence of chronic diseases that require innovative therapies. Opportunities are substantial in the development of three-dimensional cell culture systems, which offer better biomimicry, and in the advancement of cell-based product manufacturing. Companies can benefit from partnerships with academic institutions to foster innovation and the establishment of biobanks to support personalized medicine. However, challenges such as high costs of cell culture media and equipment, ethical concerns regarding animal-derived culture components, and stringent regulatory frameworks may impede growth. Innovation should focus on developing cost-efficient culture media and equipment, integrating artificial intelligence for better lab automation, and enhancing the scalability of processes for mass production. Given the dynamic nature of the market, characterized by rapid technological evolution and extensive collaboration across disciplines, the best avenues for business growth lie in emerging markets with supportive government policies and increasing healthcare investments. Establishing a robust supply chain and incorporating sustainable practices can further enhance competitiveness. For companies aiming to expand their market share, strategic investments in R&D, coupled with a focus on tailored solutions for varied industries, offer significant potential for growth and success.

KEY MARKET STATISTICS
Base Year [2023] USD 26.29 billion
Estimated Year [2024] USD 30.12 billion
Forecast Year [2030] USD 68.20 billion
CAGR (%) 14.58%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Culture Market

The Cell Culture Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for monoclonal antibodies for therapeutic applications
    • Increased investment in biotechnology and pharmaceutical research activities
    • Rising incidence of chronic diseases worldwide
  • Market Restraints
    • High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
  • Market Opportunities
    • Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
    • Burgeoning demand for cultured meat, using cell culture for sustainable food production
  • Market Challenges
    • The complexity of maintaining cultures and the risk of contamination

Porter's Five Forces: A Strategic Tool for Navigating the Cell Culture Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Culture Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Culture Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Culture Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Culture Market

A detailed market share analysis in the Cell Culture Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Culture Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Culture Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Culture Market

A strategic analysis of the Cell Culture Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kuhner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Equipment. The Consumables is further studied across Bioreactor Accessories, Sera, Media, and Reagents, and Vessels. The Sera, Media, and Reagents is further studied across Media, Reagents, and Sera. The Media is further studied across Classical Media & Salts, Serum-Free Media, Specialty Media, and Stem Cell Culture Media. The Reagents is further studied across Antibiotics/Antimycotics, Attachment & Matrix Factors, Balanced Salt Solutions, Buffers & Chemicals, Cell Dissociation Reagents, Contamination Detection Kits, and Cryoprotective Reagents. The Sera is further studied across Adult Bovine Sera and Fetal Bovine Sera. The Vessels is further studied across Cell Factory Systems/Cell Stacks, Flasks, Multiwell Plates, Petri Dishes, and Roller/Roux Bottles. The Equipment is further studied across Bioreactors, Storage Equipment, and Supporting Equipment. The Bioreactors is further studied across Conventional Bioreactors and Single-Use Bioreactors. The Storage Equipment is further studied across Cryostorage System and Refrigerators & Freezers. The Supporting Equipment is further studied across Autoclaves, Biosafety Cabinets, Carbon Dioxide Incubators, Cell Counters, Centrifuges, Filtration System, and Microscopes.
  • Based on Application, market is studied across Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Stem Cell Research, and Tissue Engineering & Regenerative Medicine. The Biopharmaceutical Production is further studied across Monoclonal Antibody Production and Vaccine Production.
  • Based on End-Use, market is studied across Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
      • 5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
      • 5.1.1.3. Rising incidence of chronic diseases worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
      • 5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
    • 5.1.4. Challenges
      • 5.1.4.1. The complexity of maintaining cultures and the risk of contamination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
    • 5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Culture Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Bioreactor Accessories
    • 6.2.2. Sera, Media, and Reagents
      • 6.2.2.1. Media
      • 6.2.2.1.1. Classical Media & Salts
      • 6.2.2.1.2. Serum-Free Media
      • 6.2.2.1.3. Specialty Media
      • 6.2.2.1.4. Stem Cell Culture Media
      • 6.2.2.2. Reagents
      • 6.2.2.2.1. Antibiotics/Antimycotics
      • 6.2.2.2.2. Attachment & Matrix Factors
      • 6.2.2.2.3. Balanced Salt Solutions
      • 6.2.2.2.4. Buffers & Chemicals
      • 6.2.2.2.5. Cell Dissociation Reagents
      • 6.2.2.2.6. Contamination Detection Kits
      • 6.2.2.2.7. Cryoprotective Reagents
      • 6.2.2.3. Sera
      • 6.2.2.3.1. Adult Bovine Sera
      • 6.2.2.3.2. Fetal Bovine Sera
    • 6.2.3. Vessels
      • 6.2.3.1. Cell Factory Systems/Cell Stacks
      • 6.2.3.2. Flasks
      • 6.2.3.3. Multiwell Plates
      • 6.2.3.4. Petri Dishes
      • 6.2.3.5. Roller/Roux Bottles
  • 6.3. Equipment
    • 6.3.1. Bioreactors
      • 6.3.1.1. Conventional Bioreactors
      • 6.3.1.2. Single-Use Bioreactors
    • 6.3.2. Storage Equipment
      • 6.3.2.1. Cryostorage System
      • 6.3.2.2. Refrigerators & Freezers
    • 6.3.3. Supporting Equipment
      • 6.3.3.1. Autoclaves
      • 6.3.3.2. Biosafety Cabinets
      • 6.3.3.3. Carbon Dioxide Incubators
      • 6.3.3.4. Cell Counters
      • 6.3.3.5. Centrifuges
      • 6.3.3.6. Filtration System
      • 6.3.3.7. Microscopes

7. Cell Culture Market, by Application

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Production
    • 7.2.1. Monoclonal Antibody Production
    • 7.2.2. Vaccine Production
  • 7.3. Diagnostics
  • 7.4. Drug Screening & Development
  • 7.5. Stem Cell Research
  • 7.6. Tissue Engineering & Regenerative Medicine

8. Cell Culture Market, by End-Use

  • 8.1. Introduction
  • 8.2. Hospitals & Diagnostic Laboratories
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutes

9. Americas Cell Culture Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Culture Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
    • 12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
    • 12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adolf Kuhner AG
  • 2. Advancion Corporation
  • 3. Agilent Technologies, Inc.
  • 4. Becton, Dickinson, and Company
  • 5. Bio-Techne Corporation
  • 6. BioSpherix Ltd.
  • 7. Caisson Labs Inc.
  • 8. CellGenix GmbH
  • 9. Corning Incorporated
  • 10. Danaher Corporation
  • 11. Emulate, Inc.
  • 12. Eppendorf AG
  • 13. Fujifilm Holdings Corporation
  • 14. Getinge AB
  • 15. Hi-Media Laboratories
  • 16. InSphero AG
  • 17. Invivogen
  • 18. Lonza Group
  • 19. Merck & Co., Inc.
  • 20. Miltenyi Biotec
  • 21. PAN-Biotech GmbH
  • 22. PromoCell GmbH
  • 23. Sartorius AG
  • 24. Solida Biotech GmBH
  • 25. STEMCELL Technologies Canada Inc.
  • 26. Synthecon, Incorporated
  • 27. Thermo Fisher Scientific Inc.
  • 28. VWR International, LLC by Avantor, Inc.

LIST OF FIGURES

  • FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. CELL CULTURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL CULTURE MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 93. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 109. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 111. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 123. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 124. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 127. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 135. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 136. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 137. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 139. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 141. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 174. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 176. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 178. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 180. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. CHINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. CHINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 189. CHINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 190. CHINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 191. CHINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 192. CHINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 193. CHINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 194. CHINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 195. CHINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 196. CHINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 197. CHINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. CHINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 199. CHINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. INDIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. INDIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 202. INDIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 203. INDIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 204. INDIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 205. INDIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 206. INDIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 207. INDIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. INDIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 209. INDIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 210. INDIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. INDIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. INDIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 213. INDIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. INDONESIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. INDONESIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 216. INDONESIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 217. INDONESIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 218. INDONESIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 219. INDONESIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 220. INDONESIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 221. INDONESIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. INDONESIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 223. INDONESIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 224. INDONESIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. INDONESIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. INDONESIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 227. INDONESIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. JAPAN CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. JAPAN CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. JAPAN CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 231. JAPAN CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 232. JAPAN CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 233. JAPAN CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 234. JAPAN CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 235. JAPAN CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 236. JAPAN CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 237. JAPAN CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 238. JAPAN CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 239. JAPAN CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. JAPAN CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 241. JAPAN CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 242. MALAYSIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. MALAYSIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 244. MALAYSIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 245. MALAYSIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 246. MALAYSIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 247. MALAYSIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 248. MALAYSIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 249. MALAYSIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 250. MALAYSIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 251. MALAYSIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 252. MALAYSIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 253. MALAYSIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. MALAYSIA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 255. MALAYSIA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 256. PHILIPPINES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 258. PHILIPPINES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 260. PHILIPPINES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 262. PHILIPPINES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 264. PHILIPPINES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 266. PHILIPPINES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. PHILIPPINES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 270. SINGAPORE CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SINGAPORE CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 272. SINGAPORE CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 273. SINGAPORE CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 274. SINGAPORE CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 275. SINGAPORE CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 276. SINGAPORE CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 277. SINGAPORE CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 278. SINGAPORE CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 279. SINGAPORE CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 280. SINGAPORE CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 281. SINGAPORE CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. SINGAPORE CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 283. SINGAPORE CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH KOREA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH KOREA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH KOREA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH KOREA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH KOREA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. SOUTH KOREA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. TAIWAN CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. TAIWAN CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 300. TAIWAN CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 301. TAIWAN CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 302. TAIWAN CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 303. TAIWAN CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 304. TAIWAN CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 305. TAIWAN CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 306. TAIWAN CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 307. TAIWAN CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 308. TAIWAN CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 309. TAIWAN CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. TAIWAN CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 311. TAIWAN CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 312. THAILAND CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. THAILAND CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 314. THAILAND CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 315. THAILAND CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 316. THAILAND CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 317. THAILAND CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 318. THAILAND CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 319. THAILAND CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 320. THAILAND CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 321. THAILAND CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 322. THAILAND CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 323. THAILAND CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. THAILAND CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 325. THAILAND CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 326. VIETNAM CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 327. VIETNAM CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 328. VIETNAM CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 329. VIETNAM CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 330. VIETNAM CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 331. VIETNAM CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 332. VIETNAM CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 333. VIETNAM CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 334. VIETNAM CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 335. VIETNAM CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 336. VIETNAM CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 337. VIETNAM CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. VIETNAM CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 339. VIETNAM CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 345. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 346. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 355. DENMARK CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 356. DENMARK CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 357. DENMARK CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 358. DENMARK CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 359. DENMARK CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 360. DENMARK CELL CULTURE MARKET SIZE, BY SERA, 2018-2030 (USD MILLION)
  • TABLE 361. DENMARK CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2030 (USD MILLION)
  • TABLE 362. DENMARK CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 363. DENMARK CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2030 (USD MILLION)
  • TABLE 364. DENMARK CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 365. DENMARK CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 366. DENMARK CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 367. DENMARK CELL CULTURE MARKET SIZE, BY BIOP